[Federal Register Volume 60, Number 190 (Monday, October 2, 1995)]
[Notices]
[Pages 51502-51503]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 95-24352]



=======================================================================
-----------------------------------------------------------------------

NATIONAL AERONAUTICS AND SPACE ADMINISTRATION

[Notice 95-090]


Notice of Prospective Patent License

AGENCY: National Aeronautics and Space Administration.

ACTION: Notice of prospective patent license.

-----------------------------------------------------------------------.


SUMMARY: NASA hereby gives notice that VivoRx Pharmaceuticals, Inc., of 
Santa Monica, California, has requested a partially exclusive license 
to practice the inventions described in: U.S. Patent No. 5,153,132 
entitled ``Three-Dimensional Co-Culture Process''; U.S. Patent No. 
5,308,764 entitled ``Multi-Cellular Three-Dimensional Living Mammalian 
Tissue''; U.S. Patent No. 5,155,034 entitled ``Three-Dimensional Cell 
to Tissue Assembly Process''; U.S. Patent No. 5,330,908 entitled ``High 
Density Cell Culture System''; U.S. Patent No. 4,839,046 entitled 
``Bio-Reactor Chamber''; U.S. Patent No. 5,026,650 entitled 
``Horizontally Rotated Cell Culture System with a Coaxial Tubular 
Oxygenator''; and U.S. Patent No. 5,002,890 entitled ``Spiral Vane Bio-
Reactor''; and the inventions disclosed in the following patent 
applications: Serial No. 08/170,488, Three-Dimensional Co-Culture 
Process''; Serial No. 08/066,292, ``Process for Complex Three-
Dimensional Co-Culture of Normal Human Small Intestine''; Serial No. 
08/277,827, ``Horizontal Rotating Ozygentator for High-Density Cell 
Culture''; Serial No. 08/172,962, ``Process for Developing High-
Fidelity Three Dimensional Tumor Models for Human Bladder Carcinoma''; 
Serial No. 08/366,065, ``Horizontal Rotating-Wall Vessel Propagation in 
Vitro Human Tissue Models''; and Serial No. 08/291,791, ``Recombinant 
Protein Production and Insect Cell Culture and Process''; all of which 
are assigned to the United States of America as represented by the 
Administrator of the National Aeronautics and Space Administration. 
Written objections to the prospective grant of a license should 

[[Page 51503]]
be sent to Mr. James M. Cate, Patent Attorney, NASA Johnson Space 
Center.

DATES: Responses to this Notice must be received by December 1, 1995.

FOR FURTHER INFORMATION CONTACT:
Mr. James M. Cate, NASA Johnson Space Center, Mail Code HA, Houston, TX 
77058; telephone number (713) 483-1001.

    Dated: September 22, 1995.
Edward A. Frankle,
General Counsel.
[FR Doc. 95-24352 Filed 9-29-95; 8:45 am]
BILLING CODE 7510-01-M